1. Home
  2. TCI vs XOMA Comparison

TCI vs XOMA Comparison

Compare TCI & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCI
  • XOMA
  • Stock Information
  • Founded
  • TCI 1983
  • XOMA 1981
  • Country
  • TCI United States
  • XOMA United States
  • Employees
  • TCI N/A
  • XOMA N/A
  • Industry
  • TCI Real Estate
  • XOMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCI Finance
  • XOMA Health Care
  • Exchange
  • TCI Nasdaq
  • XOMA Nasdaq
  • Market Cap
  • TCI 357.8M
  • XOMA 330.2M
  • IPO Year
  • TCI N/A
  • XOMA N/A
  • Fundamental
  • Price
  • TCI $45.60
  • XOMA $32.47
  • Analyst Decision
  • TCI
  • XOMA Strong Buy
  • Analyst Count
  • TCI 0
  • XOMA 2
  • Target Price
  • TCI N/A
  • XOMA $69.50
  • AVG Volume (30 Days)
  • TCI 1.8K
  • XOMA 57.0K
  • Earning Date
  • TCI 08-07-2025
  • XOMA 08-13-2025
  • Dividend Yield
  • TCI N/A
  • XOMA N/A
  • EPS Growth
  • TCI 11.20
  • XOMA N/A
  • EPS
  • TCI 0.76
  • XOMA N/A
  • Revenue
  • TCI $47,730,000.00
  • XOMA $44,952,000.00
  • Revenue This Year
  • TCI N/A
  • XOMA $82.30
  • Revenue Next Year
  • TCI N/A
  • XOMA $12.59
  • P/E Ratio
  • TCI $61.66
  • XOMA N/A
  • Revenue Growth
  • TCI N/A
  • XOMA 194.98
  • 52 Week Low
  • TCI $25.50
  • XOMA $18.35
  • 52 Week High
  • TCI $48.00
  • XOMA $35.23
  • Technical
  • Relative Strength Index (RSI)
  • TCI 56.33
  • XOMA 61.79
  • Support Level
  • TCI $46.00
  • XOMA $32.60
  • Resistance Level
  • TCI $48.00
  • XOMA $34.60
  • Average True Range (ATR)
  • TCI 0.80
  • XOMA 1.82
  • MACD
  • TCI 0.05
  • XOMA 0.09
  • Stochastic Oscillator
  • TCI 67.90
  • XOMA 66.75

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: